Compare NXPI & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NXPI | ELV |
|---|---|---|
| Founded | 2006 | 1944 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.4B | 85.7B |
| IPO Year | 2007 | 2001 |
| Metric | NXPI | ELV |
|---|---|---|
| Price | $319.17 | $388.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 19 |
| Target Price | $285.76 | ★ $383.56 |
| AVG Volume (30 Days) | ★ 3.6M | 1.4M |
| Earning Date | 04-28-2026 | 04-22-2026 |
| Dividend Yield | 1.40% | ★ 1.83% |
| EPS Growth | N/A | ★ N/A |
| EPS | 4.43 | ★ 8.00 |
| Revenue | $12,269,000,000.00 | ★ $199,125,000,000.00 |
| Revenue This Year | $12.56 | N/A |
| Revenue Next Year | $10.17 | $3.07 |
| P/E Ratio | $67.69 | ★ $49.00 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $183.00 | $273.71 |
| 52 Week High | $339.95 | $426.98 |
| Indicator | NXPI | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 55.80 | 46.87 |
| Support Level | $282.07 | $384.30 |
| Resistance Level | $339.95 | $408.00 |
| Average True Range (ATR) | 13.74 | 11.26 |
| MACD | -2.67 | -3.87 |
| Stochastic Oscillator | 71.30 | 1.43 |
NXP Semiconductors is a leading supplier of high-performance mixed-signal products. The firm acquired Freescale Semiconductor in 2015 and now has significant market share in the automotive market, where it supplies microcontrollers and analog chips into automotive clusters, powertrains, infotainment systems, and radars. NXP Semiconductors also serves industrial and Internet of Things, mobile, and communications infrastructure.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.